29.06.2013 Views

Cancer épidermoïde de l'anus - Fédération française de chirurgie ...

Cancer épidermoïde de l'anus - Fédération française de chirurgie ...

Cancer épidermoïde de l'anus - Fédération française de chirurgie ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

16. Gérard JP, Chapet O, Samiei F et al. Management of inguinal lymph no<strong>de</strong> metastases in patients with<br />

carcinoma of the anal canal. Experience in a series of 270 patients treated in Lyon and review of the<br />

literature. <strong>Cancer</strong> 2001 ; 92 : 77-84.<br />

17. Sischy B, Doggett RLS, Krall JM et al. Definitive irradiation and chemotherapy for radiosensitization in<br />

management of anal carcinoma: interim report on Radiation Therapy Oncology Group Study n° 8314. J.<br />

Natl. <strong>Cancer</strong> Inst. 1989 ; 81 : 850-6.<br />

18. Cummings B, Keane TJ, O'Sullivan B et al. Epi<strong>de</strong>rmoid anal cancer: treatment by radiation alone or by<br />

radiation and 5-fluorouracil with or without mitomycin C. Int. J. Radiat. Oncol. Biol. Phys. 1991 ; 21 : 1115-<br />

25.<br />

19. Martenson JA, Lipsitz SR, Lefkopoulou M et al. Results of combined modality therapy for patients with<br />

anal cancer (E7283). An Eastern Cooperative Oncology Group Study. <strong>Cancer</strong> 1995 ; 76 : 1731-6.<br />

20. Doci RF, Zucali R, La Monica G et al. Primary chemoradiation therapy with fluorouracil and cis platin for<br />

cancer of anus: results in 35 consecutive patients. J. Clin. Oncol. 1996 ; 14 : 3121-5.<br />

21. Martenson JA, Lipsitz SR, Wagner H et al. Initial results of phase II trial of high dose radiation therapy, 5fluorouracil,<br />

and cis platin for patients with anal cancer (E4292): an Eastern Cooperative Oncology Group<br />

Study. Int. J. Radiat. Oncol. Biol. Phys. 1996 ; 35 : 745-9.<br />

22. Hung A, Crane C, Delclos M et al. Cisplatin-based combined modality therapy for anal carcinoma. A wi<strong>de</strong>r<br />

therapeutic in<strong>de</strong>x. <strong>Cancer</strong> 2003 ; 97 : 1195-202.<br />

23. Gérard JP, Ayzac L, Hun D et al. Treatment of anal canal carcinoma with high dose radiation therapy and<br />

concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother. Oncol. 1998 ; 46 : 249-<br />

56.<br />

24. Deniaud-Alexandre E, Touboul E, Tiret E et al. Carcinomes <strong>épi<strong>de</strong>rmoï<strong>de</strong></strong> du canal anal traités par<br />

association concomitante <strong>de</strong> radiothérapie et <strong>de</strong> chimiothérapie. Evaluation <strong>de</strong>s résultats fonctionnels.<br />

<strong>Cancer</strong>/Radiother. 2006 ; 10 : 572-82.<br />

25. UKCCCR Anal <strong>Cancer</strong> Trial Working Party. Epi<strong>de</strong>rmoid anal cancer: results from UKCCCR randomised trial<br />

of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin. The Lancet 1996 ; 348 : 1049-54.<br />

26. Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to<br />

radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III trial of the<br />

European Organization for Research and Treatment of <strong>Cancer</strong> Radiotherapy and Gastrointestinal<br />

Cooperative Groups. J. Clin. Oncol. 1997 ; 15 : 2040-9.<br />

27. Ajani JA, Winter KA, Gun<strong>de</strong>rson LL et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cis<br />

platin, and radiotherapy for carcinoma of the anal canal. A randomized controlled trial. JAMA 2008 ; 299 :<br />

1914-21.<br />

28. James R, Wan S, Glynne-Jone R et al. A randomized trial of chemoradiation using mitomycin or cis platin,<br />

with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J. Clin. Oncol.<br />

2009 ; 27 : 799s, abstract LBA 4009, ASCO 2009.<br />

29. Peiffert D, Tournier-Rangeard L, Gérard JP et al. Chimiothérapie d'induction et escala<strong>de</strong> <strong>de</strong> dose pour le<br />

traitement <strong>de</strong>s cancers <strong>épi<strong>de</strong>rmoï<strong>de</strong></strong>s du canal anal localement évolués : analyse définitive <strong>de</strong> l'essai<br />

Accord 03. <strong>Cancer</strong>/Radiother. 2008 ; 12 : 708, résumé C19, SFRO 2008.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!